Predictors and Incidence of Pressure Injuries in Total Artificial Heart and Ventricular Assist Device Surgeries. Can Lipidomic Markers be a Future Diagnostic Tool?

A PRISMA systematic review of the literature was unable to identify any research indicating the incidence of predictor variables in total artificial heart (TAH) or ventricular assist device (VAD) patients. As rates of heart failure continue to rise globally, the use of VAD and TAH for end stage heart failure are increasingly becoming a standard of care. This lecture will present the results of the first research on pressure injuries in the VAD-TAH population. In addition, a new conceptual framework for pressure  injury etiology will be presented and the potential use of lipidomic markers of oxidative stress will serve as a potential source of future diagnostic instruments.